Anti-Centromere Ab by IFA (RDL)

What Does a Negative Anti-Centromere Antibody (ACA) Test Indicate?

A negative Anti-Centromere Antibody (ACA) test means that no detectable levels of ACA were found in your blood. This result suggests:

1. Lower Likelihood of Limited Systemic Sclerosis (lcSSc)

   • ACA is strongly associated with limited cutaneous systemic sclerosis (lcSSc), also known as CREST syndrome.
   • A negative ACA result reduces—but does not entirely rule out—the possibility of lcSSc. Some patients with systemic sclerosis may have other autoantibodies instead (e.g., anti-Scl-70).

2. Lower Risk of Primary Biliary Cholangitis (PBC)

   • ACA is sometimes found in primary biliary cholangitis (PBC), a chronic autoimmune liver disease.
   • A negative result reduces the likelihood of PBC, but additional liver function tests (e.g., alkaline phosphatase, AMA antibodies) may be needed if symptoms persist.

3. Other Autoimmune Diseases May Still Be Present

   • A negative ACA test does not exclude the presence of other connective tissue diseases (e.g., diffuse systemic sclerosis, lupus, or mixed connective tissue disease).
   • Additional autoantibody testing (e.g., ANA panel, anti-Scl-70, anti-RNP) may be required for a complete autoimmune evaluation.

Next Steps After a Negative ACA Test

• If symptoms persist (Raynaud’s, skin thickening, acid reflux), further rheumatologic and autoimmune testing may be necessary.
• If systemic sclerosis or another autoimmune disorder is suspected, your doctor may recommend ANA subtypes and organ function tests.
• If testing was for primary biliary cholangitis, additional liver function tests and AMA antibodies should be considered.

Key Takeaways

- A negative ACA test reduces the likelihood of limited systemic sclerosis (CREST) and primary biliary cholangitis.
- It does not rule out all autoimmune conditions—other antibodies may be involved.
- Further testing may be needed based on symptoms and medical history.

If you’re experiencing unexplained symptoms, consult with your doctor or a rheumatologist to determine if additional testing is necessary.

What Does a Positive Anti-Centromere Antibody (ACA) Test Indicate?

A positive Anti-Centromere Antibody (ACA) test suggests the presence of autoantibodies targeting centromere proteins, which are primarily associated with connective tissue autoimmune diseases. While not diagnostic on its own, a positive result is strongly linked to specific conditions, particularly:

1. Limited Cutaneous Systemic Sclerosis (lcSSc) / CREST Syndrome

• ACA is detected in 70–80% of lcSSc cases.
• Indicates a higher likelihood of skin fibrosis (tightening), Raynaud’s phenomenon, esophageal issues, and telangiectasia.
• Associated with a lower risk of severe organ involvement compared to diffuse systemic sclerosis but increased risk of pulmonary hypertension over time.

2. Primary Biliary Cholangitis (PBC)

• ACA is found in 20–30% of individuals with PBC, a chronic autoimmune liver disease.
• Often coexists with elevated liver enzymes (alkaline phosphatase, ALT, AST).
• Can lead to fatigue, itching, and liver fibrosis over time.

3. Overlap Syndromes and Other Autoimmune Diseases

• Occasionally seen in Sjogren’s syndrome, lupus, and rheumatoid arthritis, though less common.
• Some individuals with a positive ACA test do not develop an autoimmune disease but may require monitoring for symptoms.

What Should You Do Next?

If your ACA test is positive, your doctor may recommend:
- Clinical evaluation for symptoms of systemic sclerosis or PBC.
- Additional antibody tests (ANA, Scl-70, AMA) to differentiate conditions.
- Pulmonary function tests and echocardiogram to check for lung involvement.
- Liver function tests if PBC is suspected.

Key Takeaways

- A positive ACA test is most commonly associated with Limited Cutaneous Systemic Sclerosis (lcSSc) and Primary Biliary Cholangitis (PBC).
- Not everyone with a positive result develops disease, but monitoring is important.
- Further testing and clinical correlation are needed to confirm a diagnosis.

If you tested positive for ACA, consult a rheumatologist or specialist to assess potential autoimmune conditions and determine the next steps for monitoring or treatment.